France Archives

News and Trends 16 Jul 2015

Sanofi’s Extreme Makeover gives prominence to Genzyme

There seems to be a tendency towards revolution amongst Sanofi’s CEOs. Olivier Brandicourt, Managing director of the French drugmaker since his €4.1M golden handshake with the company, has come up with a restructuration plan that will reduce Sanofi’s business units from seven to five. The French businessman expects this reorganization will help the company to […]

July 16, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 16 Jul 2015

Immunocore Skyrocketed by Europe’s Largest Private Biotech Financing Ever

Immunocore Limited, just announced that it has secured a £205 million financing (€293 m) from private investors to push forward its T cell receptor (TCR) based biological drugs to treat cancer, viral infections and autoimmune diseases. This substantial amount of cash not only embodies the largest private investment ever made in Europe by a biotech company, but also the second […]

July 16, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 15 Jul 2015

How Servier saved Cellectis, the French CAR-T Miracle

Cellectis, the €1bn CAR-T company, just announced it reached a significant milestone in its collaboration with Servier. Surprisingly, early 2014, Cellectis and its 300 employees were only three months away from bankruptcy, mainly because of the competing gene-editing technology CRISPR. How and why did Servier save them? Let’s find out. Cellectis was founded in 1999 in Paris and […]

July 15, 2015 - 5 minutesmins - By Philip Hemme

News and Trends 13 Jul 2015

Researchers found the missing key factor to unleash the potential of iPS Cells

When the Nobel Prize-winning Dr. Shinya Yamanaka succeeded to generate induced pluripotent cells (iPS cells) from specialized adult cells, the field of stem cells was completely revolutionized. Since Yamanaka’s paper on adult mouse fibroblasts back in 2006, scientists have been able to perform cellular reprogramming, but the process still isn’t mastered yet. One of the […]

July 13, 2015 - 2 minutesmins - By Lourdes Riquelme

bactman synthetic biology videogame paris supbiotech

News and Trends 12 Jul 2015

Cool iGEM Project: Creating the first Synthetic Biology-based Video Game

It’s iGEM- Time, the world’s biggest synthetic biology competition! Since 2004, students are competing to create, explore and share their innovative ideas in the hot field of synthetic biology. All the teams then go to Boston (not at the MIT anymore since it’s stopped organizing the competition) to be judged and win a prize. Each year, […]

July 12, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 10 Jul 2015

Sanofi to solve Growing Resistance against Malarial Treatments

Sanofi extended its collaboration with Medicines for Malaria Venture (MMV) to jointly develop a new combination therapy against malaria, the deadliest parasitic disease worldwide. The difficult access and the fear of a growing resistance to the existing treatments highlight the importance of this partnership. Atemisinin-based combination therapies (ACT) are at this moment the most efficient […]

July 10, 2015 - 3 minutesmins - By Philip Hemme

eye Bayer Healthcare Johns Hopkins University

News and Trends 9 Jul 2015

Vision specialist Gensight eyes a €90M IPO on NASDAQ

French Gensight intends to raise one of the biggest European IPOs on the American stock market. The gene-therapy specialist will pursue €90.6M to advance with two early-stage candidates for orphan eyes diseases. Gensight will travel across the Ocean to look for the same success its compatriots had on the American stock market. The company will […]

July 9, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 7 Jul 2015

Microalgae on Your Plate Thanks to Algama

Nine billion people will have to be fed by 2050! Amongst the considered solutions, microalgae could be a real game-changer. Algama, a young French startup is in the starting-block, with already two products just about to go on the market. Behind Algama there is a friendship story, shared by the three co-founders, Alvyn, Gaëtan and Mathieu. […]

July 7, 2015 - 4 minutesmins - By Joachim Eeckhout

News and Trends 6 Jul 2015

Sartorius Stedim Strengthens its Leadership in Biologics Manufacturing with Cellca’s Acquisition

Sartorius Stedim Biotech, a leading international supplier for the pharma and biotech industries, acquired the German-based Cellca last Wednesday. With this acquisition, Sartorius is strengthening its leading position as a biologics manufacturer. Last year, we visited Cellca during our first biotech Tour in Germany. The company is offering cell line and process development for large-scale protein production […]

July 6, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 6 Jul 2015

ElsaLys Biotech grabs MABLife’s dual-acting antibody to treat cancer

French ElsaLys Biotech just acquired MABLife’s anti-CD160 antibody. Originally developed for the treatment of vascular eye diseases, the antibody also has the potential to be applied for tumor therapy. It inhibits vascular proliferation and modulates the immune system. To proliferate and migrate through the body, tumors rely on oxygen and nutrients supplies. Cancer cells initiate […]

July 6, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 2 Jul 2015

Nanobiotix got the all-clear for its new Phase I/II clinical trial

The French National Agency for Medicines and Health Products gave Nanobiotix the green light to start a Phase I/II trial in two new cancer populations for its lead product, NBTXR3. This could lead to an increase in the commercial potential of this promising French Biotech. Nanobiotix is a great French Biotech company, which you can […]

July 2, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 1 Jul 2015

Is Adocia & Eli Lilly’s treatment the new diabetes blockbuster?

Adocia and Eli Lilly completed an impressive Phase Ib clinical trial evaluating BioChaperone Lispro, a treatment designed to accelerate insulin absorption. The study aimed to compare BioChaperone Lispro to Lilly’s Humalog in type 1 diabetes patients, the former being much more effective. Humalog, Lilly’s blockbuster, is about to be ousted by Adocia’s insulin absorption accelerator. BioChaperone Lispro […]

July 1, 2015 - 2 minutesmins - By Lourdes Riquelme

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

France

Sanofi’s Extreme Makeover gives prominence to Genzyme

Immunocore Skyrocketed by Europe’s Largest Private Biotech Financing Ever

How Servier saved Cellectis, the French CAR-T Miracle

Researchers found the missing key factor to unleash the potential of iPS Cells

Cool iGEM Project: Creating the first Synthetic Biology-based Video Game

Sanofi to solve Growing Resistance against Malarial Treatments

Vision specialist Gensight eyes a €90M IPO on NASDAQ

Microalgae on Your Plate Thanks to Algama

Sartorius Stedim Strengthens its Leadership in Biologics Manufacturing with Cellca’s Acquisition

ElsaLys Biotech grabs MABLife’s dual-acting antibody to treat cancer

Nanobiotix got the all-clear for its new Phase I/II clinical trial

Is Adocia & Eli Lilly’s treatment the new diabetes blockbuster?

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!